发明名称 |
NALTREXONE LONG ACTING FORMULATIONS AND METHODS OF USE |
摘要 |
The inventions described herein arose from unexpected discoveries made during clinical trials with a long acting formulation of naltrexone. As such, the invention includes a method for treating an individual in need of naltrexone comprising the step of parenterally administering a long acting formulation comprising naltrexone and to the use of naltrexone in the manufacture of medicaments for use in such methods. |
申请公布号 |
US2014155424(A1) |
申请公布日期 |
2014.06.05 |
申请号 |
US201313871534 |
申请日期 |
2013.04.26 |
申请人 |
Alkermes, Inc. |
发明人 |
Ehrich Elliot |
分类号 |
A61K47/34;A61K31/485 |
主分类号 |
A61K47/34 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating an individual in need of naltrexone comprising the step of parenterally administering a long acting formulation comprising naltrexone to the individual wherein the serum AUC of naltrexone is at least about two times greater than that achieved by 50 mg/day oral administration.
|
地址 |
US |